Coal Tar 2% Foam in Combination with a Superpotent Corticosteroid Foam for Plaque Psoriasis Case Report and Clinical Implications

Journal of Clinical and Aesthetic Dermatology

Volumn 3, Issue 10, 2010, Pages 5-

  Frankel, Amylynne J ^a   Zeichner, Joshua A ^a   Del Rosso, James Q ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b VALLEY HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; COAL TAR; CORTICOSTEROID; EMOLLIENT AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; DERMATOLOGY; DRUG EFFICACY; ELBOW; FEMALE; FOAM; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; OUTPATIENT DEPARTMENT; PSORIASIS VULGARIS; REMISSION; TREATMENT DURATION;

EID: 78149241072     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. van de Kerkhof PC, Franssen ME. Psoriasis of the scalp. Diagnosis and management. Am J Clin Dermatol. 2001;2(3):159-165.
2. Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58(5):851-864.
3. Farley E, Masrour S, McKey J, Menter A. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol. 2009;60(6):1024-1031.
4. Sukarovska BG, Lipozencic J, Vrzogic P. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management]. Acta Med Croatica. 2007;61(4):375-381.
5. Lebwohl M, Kathryn M. New roles for systemic retinoids. J Drugs Dermatol. 2006.5(5):406-409.
6. Lebwohl M. A clinician's paradigm in the treatment of psoriasis. J Am Acad Dermatol. 2005;53(1 Suppl 1): S59-S69.
7. Kamili QU, Menter A. Topical treatment of psoriasis. Curr Probl Dermatol. 2009;38:37-58.
8. Gold LF. Calcitriol ointment: optimizing psoriasis therapy. J Drugs Dermatol. 2009;8(8 Suppl):S23-S27.
9. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643-659.
10. Koo JY. Using topical multimodal strategies for patients with psoriasis. Cutis. 2007;79(1 Suppl 2):11-17.
11. Stein Gold L, Corvari L. The roles of safety and compliance in determining effectiveness of topical therapy for psoriasis. Cutis. 2007;79(1 Suppl 2):32-38.
12. Koo JY. New developments in topical sequential therapy for psoriasis. Skin Therapy Lett. 2005;10(9):1-4.
13. Roelofzen JH, Aben KK, Khawar AJ, et al. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders. Eur J Dermatol. 2007;17(5):416-421.
14. van der Velden HM, Pasch MC, van Erp PE, et al. Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immuno-histochemical study. J Dermatolog Treat. 2010;21(1):13-22.
15. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50(3):416-430.
16. Arnold WP. Tar. Clin Dermatol. 1997;15(5):739-744.
17. Pardasani AG, Feldman SR, Clark AR. Treatment of psoriasis: an algorithm-based approach for primary care physicians. Am Fam Physician. 2000;61(3):725-733, 736.
18. Paghdal KV, Schwartz RA. Topical tar: back to the future. J Am Acad Dermatol. 2009;61(2):294-302.
19. Silverman A, Menter A, Hairston JL. Tars and anthralins. Dermatol Clin. 1995;13(4):817-833.
20. de Rie MA, Out TA, Bos JD. Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation. Dermatology. 1998;196(4):412-417.
21. Davis MD, McEvoy MT, Camilleri M, et al. Goeckerman treatment: neglected in the consensus approach for critically challenging case scenarios in moderate to severe psoriasis. J Am Acad Dermatol. 2010;62(3):508.
22. de Miguel R, el-Azhary R. Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis. Int J Dermatol. 2009;48(6):653-658.
23. Smith CH, Jackson K, Chinn S, Angus K, Barker JN. A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis. Clin Exp Dermatol. 2000;25(8):580-583.
24. Roelofzen JH, Aben KK, Oldenhof UT, et al. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. J Invest Dermatol. 2010;130(4):953-961.
25. Kumar B, Kumar R, Kaur I. Coal tar therapy in palmoplantar psoriasis: old wine in an old bottle? Int J Dermatol. 1997;36(4):309-312.